U.S., Nov. 19 -- An application to own the trademark for 'REZENOPY' has been filed on Apr. 24, 2025.
Owner(s):
Summit Biosciences, LLC; 1513 Bull Lea Rd., , KENTUCKY
Goods and/or Services:
For: Nasal spray for the treatment of opioid overdose
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-11-18&serialNumber=99153255
Disclaimer: Curated by HT Syndication....